{"transactions":[{"id":1146181,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":79715,"kind":"person","name":"Peterson Amy C.","position":1,"cik":"0001682735","reported_name":"Peterson Amy C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Prod Dev & Med Aff & CMO"}}],"security":"Option (right to buy)","published_at":"2025-05-17T00:57:07.000Z","date":"2025-05-16","kind":"exercise","planned":false,"acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option, representing the right to purchase a total of 160,000 shares of Common Stock, 40,000 shares became exercisable on August 24, 2024 and the remainder will become fully exercisable on August 24, 2027."}],"balance_after":120000,"derivative":{"exercise_price":21.75,"exercise_date":"2024-08-24","expiration_date":"2030-08-23","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0000939767-25-000076","document":"wk-form4_1747443419.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976725000076/wk-form4_1747443419.xml","form_type":"4"}},{"id":1146180,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":79715,"kind":"person","name":"Peterson Amy C.","position":1,"cik":"0001682735","reported_name":"Peterson Amy C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Prod Dev & Med Aff & CMO"}}],"security":"Common Stock","published_at":"2025-05-17T00:57:07.000Z","date":"2025-05-16","kind":"sale","planned":false,"acquired":false,"shares":72776,"price":45.47,"value":3309124.72,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $45.08 to $46.44. Reporting Person undertakes to provide Exelixis, Inc., any security\nholder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in\nfootnote 3 to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 453,166 shares of Exelixis, Inc. common stock (\"Common Stock\") that will be issued to the Reporting Person upon vesting of RSUs and performance-based restricted stock units (\"PSUs\"). Each RSU is the economic equivalent of one share of Common Stock and each PSU represents a contingent right to receive one share of Common Stock."}],"balance_after":465393,"source":{"system":"sec-edgar","filing":"0000939767-25-000076","document":"wk-form4_1747443419.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976725000076/wk-form4_1747443419.xml","form_type":"4"}},{"id":1146179,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":79715,"kind":"person","name":"Peterson Amy C.","position":1,"cik":"0001682735","reported_name":"Peterson Amy C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Prod Dev & Med Aff & CMO"}}],"security":"Common Stock","published_at":"2025-05-17T00:57:07.000Z","date":"2025-05-16","kind":"exercise","planned":false,"acquired":true,"shares":40000,"price":21.75,"value":870000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 453,166 shares of Exelixis, Inc. common stock (\"Common Stock\") that will be issued to the Reporting Person upon vesting of RSUs and performance-based restricted stock units (\"PSUs\"). Each RSU is the economic equivalent of one share of Common Stock and each PSU represents a contingent right to receive one share of Common Stock."}],"balance_after":538169,"source":{"system":"sec-edgar","filing":"0000939767-25-000076","document":"wk-form4_1747443419.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976725000076/wk-form4_1747443419.xml","form_type":"4"}},{"id":1146178,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":79715,"kind":"person","name":"Peterson Amy C.","position":1,"cik":"0001682735","reported_name":"Peterson Amy C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Prod Dev & Med Aff & CMO"}}],"security":"Common Stock","published_at":"2025-05-17T00:57:07.000Z","date":"2025-05-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":8303,"price":44.65,"value":370728.95,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of restricted stock units (\"RSUs\") awarded February 23, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 453,166 shares of Exelixis, Inc. common stock (\"Common Stock\") that will be issued to the Reporting Person upon vesting of RSUs and performance-based restricted stock units (\"PSUs\"). Each RSU is the economic equivalent of one share of Common Stock and each PSU represents a contingent right to receive one share of Common Stock."}],"balance_after":498169,"source":{"system":"sec-edgar","filing":"0000939767-25-000076","document":"wk-form4_1747443419.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976725000076/wk-form4_1747443419.xml","form_type":"4"}},{"id":1188368,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":79715,"kind":"person","name":"Peterson Amy C.","position":1,"cik":"0001682735","reported_name":"Peterson Amy C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Prod Dev & Med Aff & CMO"}}],"security":"Common Stock","published_at":"2025-03-31T23:43:42.000Z","date":"2025-03-31","kind":"grant","planned":false,"acquired":true,"shares":159383,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of performance-based restricted stock units (each, a \"PSU\") that was granted to the Reporting Person on the Transaction Date pursuant to the 2017 Equity Incentive Plan. Each PSU represents a contingent right to receive one share of Exelixis, Inc. common stock (\"Common Stock\").  The PSUs vest upon satisfaction of both (i) a performance-based condition requiring the volume-weighted average closing price of the Common Stock to equal or exceed $60 per share for any consecutive 90-calendar-day period during a five-year performance period, and (ii) a service-based condition requiring employment through the fifth anniversary of the grant date (except in the event of certain qualifying terminations of employment)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 473,696 shares of Common Stock that will be issued to the Reporting Person upon the vesting of restricted stock units (each, an \"RSU\") and the PSUs. Each RSU is the economic equivalent of one share of Common Stock."}],"balance_after":506472,"source":{"system":"sec-edgar","filing":"0000939767-25-000055","document":"wk-form4_1743464617.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976725000055/wk-form4_1743464617.xml","form_type":"4"}},{"id":1239344,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":79715,"kind":"person","name":"Peterson Amy C.","position":1,"cik":"0001682735","reported_name":"Peterson Amy C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Prod Dev & Med Aff & CMO"}}],"security":"Common Stock","published_at":"2025-03-01T01:34:57.000Z","date":"2025-02-26","kind":"grant","planned":false,"acquired":true,"shares":52192,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares of Exelixis, Inc. common stock (\"Common Stock\") that will be issued to the Reporting Person upon vesting of restricted stock units (\"RSUs\"). Each RSU is the economic equivalent of one share of Common Stock."},{"field":"date","element":"transactionDate","label":"F2","text":"The RSUs were granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The RSUs will vest as to 1/4th of the original number of shares subject to the RSU award on May 15, 2026 and thereafter as to 1/4th of the original number of shares subject to the RSU award on each May 15th until fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 314,313 shares of Common Stock that will be issued to the Reporting Person upon vesting of RSUs."}],"balance_after":347089,"source":{"system":"sec-edgar","filing":"0000939767-25-000040","document":"wk-form4_1740792891.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976725000040/wk-form4_1740792891.xml","form_type":"4"}},{"id":1360230,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":79715,"kind":"person","name":"Peterson Amy C.","position":1,"cik":"0001682735","reported_name":"Peterson Amy C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Prod Dev & Med Aff & CMO"}}],"security":"Common Stock","published_at":"2024-11-20T01:02:39.000Z","date":"2024-11-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":27224,"price":35.05,"value":954201.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of restricted stock units (\"RSUs\") awarded August 24, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 262,121 shares of Exelixis, Inc. common stock (\"Common Stock\") that will be issued to the Reporting Person upon vesting of RSUs. Each RSU is the economic equivalent of one share of Common Stock."}],"balance_after":294897,"source":{"system":"sec-edgar","filing":"0000939767-24-000158","document":"wk-form4_1732064553.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976724000158/wk-form4_1732064553.xml","form_type":"4"}},{"id":1617067,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":79715,"kind":"person","name":"Peterson Amy C.","position":1,"cik":"0001682735","reported_name":"Peterson Amy C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Prod Dev & Med Aff & CMO"}}],"security":"Common Stock","published_at":"2024-02-27T23:59:13.000Z","date":"2024-02-23","kind":"grant","planned":false,"acquired":true,"shares":82121,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Exelixis, Inc. common stock."},{"field":"date","element":"transactionDate","label":"F2","text":"The restricted stock units were granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The restricted stock units will vest as to 1/4th of the original number of shares subject to the restricted stock unit award on May 15, 2025 and thereafter as to 1/4th of the original number of shares subject to the restricted stock unit award on each May 15th until fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 322,121 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":322121,"source":{"system":"sec-edgar","filing":"0000939767-24-000035","document":"wk-form4_1709078340.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976724000035/wk-form4_1709078340.xml","form_type":"4"}},{"id":1796892,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":79715,"kind":"person","name":"Peterson Amy C.","position":1,"cik":"0001682735","reported_name":"Peterson Amy C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Prod Dev & Med Aff & CMO"}}],"security":"Option (right to buy)","published_at":"2023-08-25T23:40:47.000Z","date":"2023-08-24","kind":"grant","planned":false,"acquired":true,"shares":160000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Option granted pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. Option granted will vest as to 1/4th of the original number of shares subject to the option on the one-year anniversary of the\nTransaction Date, and thereafter as to 1/48th of the original number of shares subject to the option on each monthly anniversary of the Transaction Date."}],"balance_after":160000,"derivative":{"exercise_price":21.75,"exercise_date":"2024-08-24","expiration_date":"2030-08-23","underlying":"Common Stock","underlying_shares":160000},"source":{"system":"sec-edgar","filing":"0000939767-23-000098","document":"wk-form4_1693006836.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976723000098/wk-form4_1693006836.xml","form_type":"4"}},{"id":1796891,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":79715,"kind":"person","name":"Peterson Amy C.","position":1,"cik":"0001682735","reported_name":"Peterson Amy C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Prod Dev & Med Aff & CMO"}}],"security":"Common Stock","published_at":"2023-08-25T23:40:47.000Z","date":"2023-08-24","kind":"grant","planned":false,"acquired":true,"shares":240000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Exelixis, Inc. common stock."},{"field":"date","element":"transactionDate","label":"F2","text":"The restricted stock units were granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The restricted stock units will vest as to 1/4th of the original\nnumber of shares subject to the restricted stock unit award on November 15, 2024 and thereafter as to 1/4th of the original number of shares subject to the restricted stock unit award on each November 15th until fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 240,000 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":240000,"source":{"system":"sec-edgar","filing":"0000939767-23-000098","document":"wk-form4_1693006836.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976723000098/wk-form4_1693006836.xml","form_type":"4"}},{"id":1944184,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":79715,"kind":"person","name":"Peterson Amy C.","position":1,"cik":"0001682735","reported_name":"Peterson Amy C.","relationship":{"officer":true,"officer_title":"EVP, Chief Development Officer"}}],"security":"Common Stock","published_at":"2023-03-20T22:43:26.000Z","date":"2023-03-16","kind":"sale","planned":false,"acquired":false,"shares":4257,"price":1.979,"value":8424.603,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 30,000 restricted stock units."}],"balance_after":58433,"source":{"system":"sec-edgar","filing":"0001140361-23-012614","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000114036123012614/form4.xml","form_type":"4"}},{"id":2203774,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":79715,"kind":"person","name":"Peterson Amy C.","position":1,"cik":"0001682735","reported_name":"Peterson Amy C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Common Stock","published_at":"2022-07-21T20:11:42.000Z","date":"2022-07-20","kind":"sale","acquired":false,"shares":7463,"price":1.422,"value":10612.386,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of shares subject to a PSU of the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 40,000 restricted stock units."}],"balance_after":62690,"source":{"system":"sec-edgar","filing":"0001567619-22-014301","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761922014301/doc1.xml","form_type":"4"}},{"id":2203773,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":79715,"kind":"person","name":"Peterson Amy C.","position":1,"cik":"0001682735","reported_name":"Peterson Amy C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Common Stock","published_at":"2022-07-21T20:11:42.000Z","date":"2022-07-19","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents Performance Stock Units (\"PSUs\") initially granted on October 24, 2021 that were subject to a performance-based vesting condition. The first milestone vesting condition was determined to be satisfied upon which 50% of the PSUs vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 40,000 restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Reflects the adjusted total which includes the purchase of 3,732 shares under the Cytomx Therapeutics Employee Stock Purchase Plan on May 31, 2022."}],"balance_after":70153,"source":{"system":"sec-edgar","filing":"0001567619-22-014301","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761922014301/doc1.xml","form_type":"4"}},{"id":2411404,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":79715,"kind":"person","name":"Peterson Amy C.","position":1,"cik":"0001682735","reported_name":"Peterson Amy C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-04T21:53:46.000Z","date":"2022-02-02","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/48th of the shares subject to the option vest on each monthly anniversary measured from February 2, 2022 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such date."}],"balance_after":200000,"derivative":{"exercise_price":4.13,"expiration_date":"2032-02-01","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001567619-22-002525","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761922002525/doc1.xml","form_type":"4"}},{"id":2411403,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":79715,"kind":"person","name":"Peterson Amy C.","position":1,"cik":"0001682735","reported_name":"Peterson Amy C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Common Stock","published_at":"2022-02-04T21:53:46.000Z","date":"2022-02-02","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 1/4th of the RSUs vest annually on March 15 of each year, with the first 1/4th vesting on March 15, 2023, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 40,000 RSUs."}],"balance_after":46421,"source":{"system":"sec-edgar","filing":"0001567619-22-002525","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761922002525/doc1.xml","form_type":"4"}},{"id":2534391,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":79715,"kind":"person","name":"Peterson Amy C.","position":1,"cik":"0001682735","reported_name":"Peterson Amy C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Performance Stock Units (PSUs)","published_at":"2021-10-26T20:26:18.000Z","date":"2021-10-24","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Performance Stock Unit (\"PSU\") represents a contingent right to receive one share of the Issuer's Common Stock upon vesting. 50% of the PSUs vest upon achievement of a certain performance-based milestone within 1 year from grant date and 50% of the PSUs vest upon achievement of a certain performance-based milestone within 2 years from grant date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each Performance Stock Unit (\"PSU\") represents a contingent right to receive one share of the Issuer's Common Stock upon vesting. 50% of the PSUs vest upon achievement of a certain performance-based milestone within 1 year from grant date and 50% of the PSUs vest upon achievement of a certain performance-based milestone within 2 years from grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each Performance Stock Unit (\"PSU\") represents a contingent right to receive one share of the Issuer's Common Stock upon vesting. 50% of the PSUs vest upon achievement of a certain performance-based milestone within 1 year from grant date and 50% of the PSUs vest upon achievement of a certain performance-based milestone within 2 years from grant date."}],"balance_after":40000,"derivative":{"underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001567619-21-018718","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761921018718/doc1.xml","form_type":"4"}},{"id":2534390,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":79715,"kind":"person","name":"Peterson Amy C.","position":1,"cik":"0001682735","reported_name":"Peterson Amy C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-10-26T20:26:18.000Z","date":"2021-10-24","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option vest on each monthly anniversary measured from October 24, 2021 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such date."}],"balance_after":50000,"derivative":{"exercise_price":5.34,"expiration_date":"2031-10-23","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001567619-21-018718","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761921018718/doc1.xml","form_type":"4"}},{"id":2677098,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":79715,"kind":"person","name":"Peterson Amy C.","position":1,"cik":"0001682735","reported_name":"Peterson Amy C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Common Stock","published_at":"2021-06-08T17:07:11.000Z","date":"2021-05-31","kind":"grant","acquired":true,"shares":3320,"price":6.086,"value":20205.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"3,320 shares were acquired pursuant to the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":6421,"source":{"system":"sec-edgar","filing":"0001567619-21-011806","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761921011806/doc1.xml","form_type":"4"}},{"id":2818999,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":79715,"kind":"person","name":"Peterson Amy C.","position":1,"cik":"0001682735","reported_name":"Peterson Amy C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-03-02T22:07:20.000Z","date":"2021-02-26","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option vest on each monthly anniversary measured from February 26, 2021 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such date."}],"balance_after":250000,"derivative":{"exercise_price":7.85,"expiration_date":"2031-02-25","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001567619-21-005402","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761921005402/doc1.xml","form_type":"4"}},{"id":2954882,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":79715,"kind":"person","name":"Peterson Amy C.","position":1,"cik":"0001682735","reported_name":"Peterson Amy C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Common Stock","published_at":"2020-12-07T21:59:46.000Z","date":"2020-11-30","kind":"grant","acquired":true,"shares":3101,"price":6.392,"value":19821.592,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"3,101 shares were acquired pursuant to the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":3101,"source":{"system":"sec-edgar","filing":"0001567619-20-020709","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761920020709/doc1.xml","form_type":"4"}},{"id":3262240,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":79715,"kind":"person","name":"Peterson Amy C.","position":1,"cik":"0001682735","reported_name":"Peterson Amy C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-02-19T23:38:25.000Z","date":"2020-02-14","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option vest on each monthly anniversary measured from January 1, 2020 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such date."}],"balance_after":25000,"derivative":{"exercise_price":7.13,"expiration_date":"2030-02-13","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001567619-20-004346","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761920004346/doc1.xml","form_type":"4"}},{"id":3392729,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":79715,"kind":"person","name":"Peterson Amy C.","position":1,"cik":"0001682735","reported_name":"Peterson Amy C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-10-16T23:01:49.000Z","date":"2019-10-15","kind":"grant","acquired":true,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the Inducement Option Award will vest and become exercisable as to 25% of the total number of shares subject to the option on October 14, 2020 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date."}],"balance_after":400000,"derivative":{"exercise_price":7.16,"expiration_date":"2029-10-14","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001567619-19-019675","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761919019675/doc1.xml","form_type":"4"}},{"id":3724265,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":79715,"kind":"person","name":"Peterson Amy C.","position":1,"cik":"0001682735","reported_name":"Peterson Amy C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Immuno-oncology"}}],"security":"Share Option (Right to Buy)","published_at":"2018-12-19T23:34:10.000Z","date":"2018-12-18","kind":"exercise","acquired":false,"shares":131833,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F16","text":"The number of securities underlying each option and the exercise price therefor are represented in ordinary shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F17","text":"These securities vest over a four-year period as follows: 25% on the first anniversary of August 22, 2016 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service.  All unvested shares subject to this option are subject to accelerated vesting upon certain termination events."}],"balance_after":820000,"derivative":{"exercise_price":2.24,"expiration_date":"2026-08-21","underlying":"Ordinary Shares","underlying_shares":131833},"source":{"system":"sec-edgar","filing":"0001651308-18-000018","document":"wf-form4_154526243150998.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130818000018/wf-form4_154526243150998.xml","form_type":"4"}},{"id":3724264,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":79715,"kind":"person","name":"Peterson Amy C.","position":1,"cik":"0001682735","reported_name":"Peterson Amy C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Immuno-oncology"}}],"security":"Share Option (Right to Buy)","published_at":"2018-12-19T23:34:10.000Z","date":"2018-12-17","kind":"exercise","acquired":false,"shares":128167,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F16","text":"The number of securities underlying each option and the exercise price therefor are represented in ordinary shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F17","text":"These securities vest over a four-year period as follows: 25% on the first anniversary of August 22, 2016 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service.  All unvested shares subject to this option are subject to accelerated vesting upon certain termination events."}],"balance_after":951833,"derivative":{"exercise_price":2.24,"expiration_date":"2026-08-21","underlying":"Ordinary Shares","underlying_shares":128167},"source":{"system":"sec-edgar","filing":"0001651308-18-000018","document":"wf-form4_154526243150998.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130818000018/wf-form4_154526243150998.xml","form_type":"4"}},{"id":3724263,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":79715,"kind":"person","name":"Peterson Amy C.","position":1,"cik":"0001682735","reported_name":"Peterson Amy C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Immuno-oncology"}}],"security":"American Depositary Shares","published_at":"2018-12-19T23:34:10.000Z","date":"2018-12-18","kind":"sale","acquired":false,"shares":611,"price":135.5422,"value":82816.2842,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F15","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $135.40 to $136.3999, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001651308-18-000018","document":"wf-form4_154526243150998.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130818000018/wf-form4_154526243150998.xml","form_type":"4"}},{"id":3724262,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":79715,"kind":"person","name":"Peterson Amy C.","position":1,"cik":"0001682735","reported_name":"Peterson Amy C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Immuno-oncology"}}],"security":"American Depositary Shares","published_at":"2018-12-19T23:34:10.000Z","date":"2018-12-18","kind":"sale","acquired":false,"shares":3600,"price":134.8099,"value":485315.64,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F14","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $134.37 to $135.3699, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price."}],"balance_after":611,"source":{"system":"sec-edgar","filing":"0001651308-18-000018","document":"wf-form4_154526243150998.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130818000018/wf-form4_154526243150998.xml","form_type":"4"}},{"id":3724261,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":79715,"kind":"person","name":"Peterson Amy C.","position":1,"cik":"0001682735","reported_name":"Peterson Amy C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Immuno-oncology"}}],"security":"American Depositary Shares","published_at":"2018-12-19T23:34:10.000Z","date":"2018-12-18","kind":"sale","acquired":false,"shares":2402,"price":133.8822,"value":321585.0444,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F13","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $133.32 to $134.3199, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price."}],"balance_after":4211,"source":{"system":"sec-edgar","filing":"0001651308-18-000018","document":"wf-form4_154526243150998.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130818000018/wf-form4_154526243150998.xml","form_type":"4"}},{"id":3724260,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":79715,"kind":"person","name":"Peterson Amy C.","position":1,"cik":"0001682735","reported_name":"Peterson Amy C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Immuno-oncology"}}],"security":"American Depositary Shares","published_at":"2018-12-19T23:34:10.000Z","date":"2018-12-18","kind":"sale","acquired":false,"shares":1897,"price":132.7018,"value":251735.3146,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F12","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $132.22 to $133.2199, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price."}],"balance_after":6613,"source":{"system":"sec-edgar","filing":"0001651308-18-000018","document":"wf-form4_154526243150998.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130818000018/wf-form4_154526243150998.xml","form_type":"4"}},{"id":3724259,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":79715,"kind":"person","name":"Peterson Amy C.","position":1,"cik":"0001682735","reported_name":"Peterson Amy C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Immuno-oncology"}}],"security":"American Depositary Shares","published_at":"2018-12-19T23:34:10.000Z","date":"2018-12-18","kind":"sale","acquired":false,"shares":1631,"price":131.735,"value":214859.785,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $131.01 to $132.0099, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price."}],"balance_after":8510,"source":{"system":"sec-edgar","filing":"0001651308-18-000018","document":"wf-form4_154526243150998.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130818000018/wf-form4_154526243150998.xml","form_type":"4"}},{"id":3724258,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":79715,"kind":"person","name":"Peterson Amy C.","position":1,"cik":"0001682735","reported_name":"Peterson Amy C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Immuno-oncology"}}],"security":"American Depositary Shares","published_at":"2018-12-19T23:34:10.000Z","date":"2018-12-18","kind":"exercise","acquired":true,"shares":10141,"price":29.1,"value":295103.1,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The exercise price is represented in American Depositary Shares."}],"balance_after":10141,"source":{"system":"sec-edgar","filing":"0001651308-18-000018","document":"wf-form4_154526243150998.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130818000018/wf-form4_154526243150998.xml","form_type":"4"}},{"id":3724257,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":79715,"kind":"person","name":"Peterson Amy C.","position":1,"cik":"0001682735","reported_name":"Peterson Amy C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Immuno-oncology"}}],"security":"American Depositary Shares","published_at":"2018-12-19T23:34:10.000Z","date":"2018-12-17","kind":"sale","acquired":false,"shares":480,"price":136.93,"value":65726.4,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $136.65 to $137.6499, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares, sold at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001651308-18-000018","document":"wf-form4_154526243150998.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130818000018/wf-form4_154526243150998.xml","form_type":"4"}},{"id":3724256,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":79715,"kind":"person","name":"Peterson Amy C.","position":1,"cik":"0001682735","reported_name":"Peterson Amy C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Immuno-oncology"}}],"security":"American Depositary Shares","published_at":"2018-12-19T23:34:10.000Z","date":"2018-12-17","kind":"sale","acquired":false,"shares":2296,"price":136.2446,"value":312817.6016,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $135.61 to $136.6099, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares, sold at each separate price."}],"balance_after":480,"source":{"system":"sec-edgar","filing":"0001651308-18-000018","document":"wf-form4_154526243150998.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130818000018/wf-form4_154526243150998.xml","form_type":"4"}},{"id":3724255,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":79715,"kind":"person","name":"Peterson Amy C.","position":1,"cik":"0001682735","reported_name":"Peterson Amy C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Immuno-oncology"}}],"security":"American Depositary Shares","published_at":"2018-12-19T23:34:10.000Z","date":"2018-12-17","kind":"sale","acquired":false,"shares":778,"price":135.0446,"value":105064.6988,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $134.60 to $135.5999, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares, sold at each separate price."}],"balance_after":2776,"source":{"system":"sec-edgar","filing":"0001651308-18-000018","document":"wf-form4_154526243150998.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130818000018/wf-form4_154526243150998.xml","form_type":"4"}},{"id":3724254,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":79715,"kind":"person","name":"Peterson Amy C.","position":1,"cik":"0001682735","reported_name":"Peterson Amy C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Immuno-oncology"}}],"security":"American Depositary Shares","published_at":"2018-12-19T23:34:10.000Z","date":"2018-12-17","kind":"sale","acquired":false,"shares":1005,"price":133.8095,"value":134478.5475,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $133.43 to $134.4299, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares, sold at each separate price."}],"balance_after":3554,"source":{"system":"sec-edgar","filing":"0001651308-18-000018","document":"wf-form4_154526243150998.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130818000018/wf-form4_154526243150998.xml","form_type":"4"}},{"id":3724253,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":79715,"kind":"person","name":"Peterson Amy C.","position":1,"cik":"0001682735","reported_name":"Peterson Amy C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Immuno-oncology"}}],"security":"American Depositary Shares","published_at":"2018-12-19T23:34:10.000Z","date":"2018-12-17","kind":"sale","acquired":false,"shares":1700,"price":132.9137,"value":225953.29,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $132.42 to $133.4199, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares, sold at each separate price."}],"balance_after":4559,"source":{"system":"sec-edgar","filing":"0001651308-18-000018","document":"wf-form4_154526243150998.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130818000018/wf-form4_154526243150998.xml","form_type":"4"}},{"id":3724252,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":79715,"kind":"person","name":"Peterson Amy C.","position":1,"cik":"0001682735","reported_name":"Peterson Amy C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Immuno-oncology"}}],"security":"American Depositary Shares","published_at":"2018-12-19T23:34:10.000Z","date":"2018-12-17","kind":"sale","acquired":false,"shares":2700,"price":131.7972,"value":355852.44,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $131.38 to $132.3799, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares, sold at each separate price."}],"balance_after":6259,"source":{"system":"sec-edgar","filing":"0001651308-18-000018","document":"wf-form4_154526243150998.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130818000018/wf-form4_154526243150998.xml","form_type":"4"}},{"id":3724251,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":79715,"kind":"person","name":"Peterson Amy C.","position":1,"cik":"0001682735","reported_name":"Peterson Amy C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Immuno-oncology"}}],"security":"American Depositary Shares","published_at":"2018-12-19T23:34:10.000Z","date":"2018-12-17","kind":"sale","acquired":false,"shares":900,"price":130.3678,"value":117331.02,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $130.16 to $131.1599, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares, sold at each separate price."}],"balance_after":8959,"source":{"system":"sec-edgar","filing":"0001651308-18-000018","document":"wf-form4_154526243150998.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130818000018/wf-form4_154526243150998.xml","form_type":"4"}},{"id":3724250,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":79715,"kind":"person","name":"Peterson Amy C.","position":1,"cik":"0001682735","reported_name":"Peterson Amy C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Immuno-oncology"}}],"security":"American Depositary Shares","published_at":"2018-12-19T23:34:10.000Z","date":"2018-12-17","kind":"exercise","acquired":true,"shares":9859,"price":29.1,"value":286896.9,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The exercise price is represented in American Depositary Shares."}],"balance_after":9859,"source":{"system":"sec-edgar","filing":"0001651308-18-000018","document":"wf-form4_154526243150998.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130818000018/wf-form4_154526243150998.xml","form_type":"4"}},{"id":3766217,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":79715,"kind":"person","name":"Peterson Amy C.","position":1,"cik":"0001682735","reported_name":"Peterson Amy C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Immuno-oncology"}}],"security":"Share Option (Right to Buy)","published_at":"2018-11-13T15:20:27.000Z","date":"2018-11-12","kind":"exercise","acquired":false,"shares":156871,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F24","text":"The number of securities underlying each option and the exercise price therefor are represented in ordinary shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F25","text":"These securities vest over a four-year period as follows: 25% on the first anniversary of August 22, 2016 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service.  All unvested shares subject to this option are subject to accelerated vesting upon certain termination events."}],"balance_after":1080000,"derivative":{"exercise_price":2.24,"expiration_date":"2026-08-21","underlying":"Ordinary Shares","underlying_shares":156871},"source":{"system":"sec-edgar","filing":"0001682735-18-000003","document":"wf-form4_154212240992906.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":27,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000168273518000003/wf-form4_154212240992906.xml","form_type":"4"}},{"id":3766216,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":79715,"kind":"person","name":"Peterson Amy C.","position":1,"cik":"0001682735","reported_name":"Peterson Amy C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Immuno-oncology"}}],"security":"Share Option (Right to Buy)","published_at":"2018-11-13T15:20:27.000Z","date":"2018-11-09","kind":"exercise","acquired":false,"shares":171886,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F24","text":"The number of securities underlying each option and the exercise price therefor are represented in ordinary shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F25","text":"These securities vest over a four-year period as follows: 25% on the first anniversary of August 22, 2016 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service.  All unvested shares subject to this option are subject to accelerated vesting upon certain termination events."}],"balance_after":1236871,"derivative":{"exercise_price":2.24,"expiration_date":"2026-08-21","underlying":"Ordinary Shares","underlying_shares":171886},"source":{"system":"sec-edgar","filing":"0001682735-18-000003","document":"wf-form4_154212240992906.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":26,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000168273518000003/wf-form4_154212240992906.xml","form_type":"4"}},{"id":3766215,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":79715,"kind":"person","name":"Peterson Amy C.","position":1,"cik":"0001682735","reported_name":"Peterson Amy C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Immuno-oncology"}}],"security":"Share Option (Right to Buy)","published_at":"2018-11-13T15:20:27.000Z","date":"2018-11-08","kind":"exercise","acquired":false,"shares":191243,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F24","text":"The number of securities underlying each option and the exercise price therefor are represented in ordinary shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F25","text":"These securities vest over a four-year period as follows: 25% on the first anniversary of August 22, 2016 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service.  All unvested shares subject to this option are subject to accelerated vesting upon certain termination events."}],"balance_after":1408757,"derivative":{"exercise_price":2.24,"expiration_date":"2026-08-21","underlying":"Ordinary Shares","underlying_shares":191243},"source":{"system":"sec-edgar","filing":"0001682735-18-000003","document":"wf-form4_154212240992906.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":25,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000168273518000003/wf-form4_154212240992906.xml","form_type":"4"}},{"id":3766214,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":79715,"kind":"person","name":"Peterson Amy C.","position":1,"cik":"0001682735","reported_name":"Peterson Amy C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Immuno-oncology"}}],"security":"American Depositary Shares","published_at":"2018-11-13T15:20:27.000Z","date":"2018-11-12","kind":"sale","acquired":false,"shares":100,"price":121.56,"value":12156.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F23","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.56 to $122.5599, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares, sold at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001682735-18-000003","document":"wf-form4_154212240992906.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":24,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000168273518000003/wf-form4_154212240992906.xml","form_type":"4"}},{"id":3766213,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":79715,"kind":"person","name":"Peterson Amy C.","position":1,"cik":"0001682735","reported_name":"Peterson Amy C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Immuno-oncology"}}],"security":"American Depositary Shares","published_at":"2018-11-13T15:20:27.000Z","date":"2018-11-12","kind":"sale","acquired":false,"shares":109,"price":117.6106,"value":12819.5554,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F22","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $116.84 to $117.8399, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares, sold at each separate price."}],"balance_after":100,"source":{"system":"sec-edgar","filing":"0001682735-18-000003","document":"wf-form4_154212240992906.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":23,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000168273518000003/wf-form4_154212240992906.xml","form_type":"4"}},{"id":3766212,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":79715,"kind":"person","name":"Peterson Amy C.","position":1,"cik":"0001682735","reported_name":"Peterson Amy C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Immuno-oncology"}}],"security":"American Depositary Shares","published_at":"2018-11-13T15:20:27.000Z","date":"2018-11-12","kind":"sale","acquired":false,"shares":500,"price":116.5623,"value":58281.15,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F21","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.82 to $116.8199, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares, sold at each separate price."}],"balance_after":209,"source":{"system":"sec-edgar","filing":"0001682735-18-000003","document":"wf-form4_154212240992906.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":22,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000168273518000003/wf-form4_154212240992906.xml","form_type":"4"}},{"id":3766211,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":79715,"kind":"person","name":"Peterson Amy C.","position":1,"cik":"0001682735","reported_name":"Peterson Amy C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Immuno-oncology"}}],"security":"American Depositary Shares","published_at":"2018-11-13T15:20:27.000Z","date":"2018-11-12","kind":"sale","acquired":false,"shares":700,"price":114.96,"value":80472.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F20","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $114.63 to $115.6299, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares, sold at each separate price."}],"balance_after":709,"source":{"system":"sec-edgar","filing":"0001682735-18-000003","document":"wf-form4_154212240992906.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000168273518000003/wf-form4_154212240992906.xml","form_type":"4"}},{"id":3766210,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":79715,"kind":"person","name":"Peterson Amy C.","position":1,"cik":"0001682735","reported_name":"Peterson Amy C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Immuno-oncology"}}],"security":"American Depositary Shares","published_at":"2018-11-13T15:20:27.000Z","date":"2018-11-12","kind":"sale","acquired":false,"shares":1173,"price":113.9216,"value":133630.0368,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F19","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $113.63 to $114.6299, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares, sold at each separate price."}],"balance_after":1409,"source":{"system":"sec-edgar","filing":"0001682735-18-000003","document":"wf-form4_154212240992906.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000168273518000003/wf-form4_154212240992906.xml","form_type":"4"}},{"id":3766209,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":79715,"kind":"person","name":"Peterson Amy C.","position":1,"cik":"0001682735","reported_name":"Peterson Amy C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Immuno-oncology"}}],"security":"American Depositary Shares","published_at":"2018-11-13T15:20:27.000Z","date":"2018-11-12","kind":"sale","acquired":false,"shares":2527,"price":113.0322,"value":285632.3694,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F18","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $112.61 to $113.6099, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares, sold at each separate price."}],"balance_after":2582,"source":{"system":"sec-edgar","filing":"0001682735-18-000003","document":"wf-form4_154212240992906.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000168273518000003/wf-form4_154212240992906.xml","form_type":"4"}},{"id":3766208,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":79715,"kind":"person","name":"Peterson Amy C.","position":1,"cik":"0001682735","reported_name":"Peterson Amy C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Immuno-oncology"}}],"security":"American Depositary Shares","published_at":"2018-11-13T15:20:27.000Z","date":"2018-11-12","kind":"sale","acquired":false,"shares":4000,"price":112.1801,"value":448720.4,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F17","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.61 to $112.6099, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price."}],"balance_after":5109,"source":{"system":"sec-edgar","filing":"0001682735-18-000003","document":"wf-form4_154212240992906.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000168273518000003/wf-form4_154212240992906.xml","form_type":"4"}},{"id":3766207,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":79715,"kind":"person","name":"Peterson Amy C.","position":1,"cik":"0001682735","reported_name":"Peterson Amy C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Immuno-oncology"}}],"security":"American Depositary Shares","published_at":"2018-11-13T15:20:27.000Z","date":"2018-11-12","kind":"sale","acquired":false,"shares":2958,"price":111.1013,"value":328637.6454,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F16","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.50 to $111.4999, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares, sold at each separate price."}],"balance_after":9109,"source":{"system":"sec-edgar","filing":"0001682735-18-000003","document":"wf-form4_154212240992906.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000168273518000003/wf-form4_154212240992906.xml","form_type":"4"}},{"id":3766206,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":79715,"kind":"person","name":"Peterson Amy C.","position":1,"cik":"0001682735","reported_name":"Peterson Amy C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Immuno-oncology"}}],"security":"American Depositary Shares","published_at":"2018-11-13T15:20:27.000Z","date":"2018-11-12","kind":"exercise","acquired":true,"shares":12067,"price":29.1,"value":351149.7,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The exercise price is represented in American Depositary Shares."}],"balance_after":12067,"source":{"system":"sec-edgar","filing":"0001682735-18-000003","document":"wf-form4_154212240992906.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000168273518000003/wf-form4_154212240992906.xml","form_type":"4"}},{"id":3766205,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":79715,"kind":"person","name":"Peterson Amy C.","position":1,"cik":"0001682735","reported_name":"Peterson Amy C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Immuno-oncology"}}],"security":"American Depositary Shares","published_at":"2018-11-13T15:20:27.000Z","date":"2018-11-09","kind":"sale","acquired":false,"shares":100,"price":125.97,"value":12597.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F15","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $125.97 to $126.9699, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares, sold at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001682735-18-000003","document":"wf-form4_154212240992906.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000168273518000003/wf-form4_154212240992906.xml","form_type":"4"}},{"id":3766204,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":79715,"kind":"person","name":"Peterson Amy C.","position":1,"cik":"0001682735","reported_name":"Peterson Amy C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Immuno-oncology"}}],"security":"American Depositary Shares","published_at":"2018-11-13T15:20:27.000Z","date":"2018-11-09","kind":"sale","acquired":false,"shares":322,"price":123.7476,"value":39846.7272,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F14","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $123.50 to $124.4999, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares, sold at each separate price."}],"balance_after":100,"source":{"system":"sec-edgar","filing":"0001682735-18-000003","document":"wf-form4_154212240992906.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000168273518000003/wf-form4_154212240992906.xml","form_type":"4"}},{"id":3766203,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":79715,"kind":"person","name":"Peterson Amy C.","position":1,"cik":"0001682735","reported_name":"Peterson Amy C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Immuno-oncology"}}],"security":"American Depositary Shares","published_at":"2018-11-13T15:20:27.000Z","date":"2018-11-09","kind":"sale","acquired":false,"shares":2046,"price":122.5478,"value":250732.7988,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F13","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $122.21 to $123.2099, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares, sold at each separate price."}],"balance_after":422,"source":{"system":"sec-edgar","filing":"0001682735-18-000003","document":"wf-form4_154212240992906.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000168273518000003/wf-form4_154212240992906.xml","form_type":"4"}},{"id":3766202,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":79715,"kind":"person","name":"Peterson Amy C.","position":1,"cik":"0001682735","reported_name":"Peterson Amy C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Immuno-oncology"}}],"security":"American Depositary Shares","published_at":"2018-11-13T15:20:27.000Z","date":"2018-11-09","kind":"sale","acquired":false,"shares":2898,"price":121.7059,"value":352703.6982,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F12","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.18 to $122.1799, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares, sold at each separate price."}],"balance_after":2468,"source":{"system":"sec-edgar","filing":"0001682735-18-000003","document":"wf-form4_154212240992906.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000168273518000003/wf-form4_154212240992906.xml","form_type":"4"}},{"id":3766201,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":79715,"kind":"person","name":"Peterson Amy C.","position":1,"cik":"0001682735","reported_name":"Peterson Amy C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Immuno-oncology"}}],"security":"American Depositary Shares","published_at":"2018-11-13T15:20:27.000Z","date":"2018-11-09","kind":"sale","acquired":false,"shares":2100,"price":120.631,"value":253325.1,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $120.14 to $121.1399, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares, sold at each separate price."}],"balance_after":5366,"source":{"system":"sec-edgar","filing":"0001682735-18-000003","document":"wf-form4_154212240992906.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000168273518000003/wf-form4_154212240992906.xml","form_type":"4"}},{"id":3766200,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":79715,"kind":"person","name":"Peterson Amy C.","position":1,"cik":"0001682735","reported_name":"Peterson Amy C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Immuno-oncology"}}],"security":"American Depositary Shares","published_at":"2018-11-13T15:20:27.000Z","date":"2018-11-09","kind":"sale","acquired":false,"shares":1725,"price":119.2694,"value":205739.715,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $119.01 to $120.0099, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares, sold at each separate price."}],"balance_after":7466,"source":{"system":"sec-edgar","filing":"0001682735-18-000003","document":"wf-form4_154212240992906.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000168273518000003/wf-form4_154212240992906.xml","form_type":"4"}},{"id":3766199,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":79715,"kind":"person","name":"Peterson Amy C.","position":1,"cik":"0001682735","reported_name":"Peterson Amy C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Immuno-oncology"}}],"security":"American Depositary Shares","published_at":"2018-11-13T15:20:27.000Z","date":"2018-11-09","kind":"sale","acquired":false,"shares":4031,"price":118.635,"value":478217.685,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $118.01 to $119.0099, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares, sold at each separate price."}],"balance_after":9191,"source":{"system":"sec-edgar","filing":"0001682735-18-000003","document":"wf-form4_154212240992906.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000168273518000003/wf-form4_154212240992906.xml","form_type":"4"}},{"id":3766198,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":79715,"kind":"person","name":"Peterson Amy C.","position":1,"cik":"0001682735","reported_name":"Peterson Amy C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Immuno-oncology"}}],"security":"American Depositary Shares","published_at":"2018-11-13T15:20:27.000Z","date":"2018-11-09","kind":"exercise","acquired":true,"shares":13222,"price":29.1,"value":384760.2,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The exercise price is represented in American Depositary Shares."}],"balance_after":13222,"source":{"system":"sec-edgar","filing":"0001682735-18-000003","document":"wf-form4_154212240992906.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000168273518000003/wf-form4_154212240992906.xml","form_type":"4"}},{"id":3766197,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":79715,"kind":"person","name":"Peterson Amy C.","position":1,"cik":"0001682735","reported_name":"Peterson Amy C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Immuno-oncology"}}],"security":"American Depositary Shares","published_at":"2018-11-13T15:20:27.000Z","date":"2018-11-08","kind":"sale","acquired":false,"shares":200,"price":127.6075,"value":25521.5,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $127.50 to $128.4999, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares, sold at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001682735-18-000003","document":"wf-form4_154212240992906.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000168273518000003/wf-form4_154212240992906.xml","form_type":"4"}},{"id":3766196,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":79715,"kind":"person","name":"Peterson Amy C.","position":1,"cik":"0001682735","reported_name":"Peterson Amy C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Immuno-oncology"}}],"security":"American Depositary Shares","published_at":"2018-11-13T15:20:27.000Z","date":"2018-11-08","kind":"sale","acquired":false,"shares":7673,"price":126.7197,"value":972320.2581,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.4616 to $127.4615, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares, sold at each separate price."}],"balance_after":200,"source":{"system":"sec-edgar","filing":"0001682735-18-000003","document":"wf-form4_154212240992906.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000168273518000003/wf-form4_154212240992906.xml","form_type":"4"}},{"id":3766195,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":79715,"kind":"person","name":"Peterson Amy C.","position":1,"cik":"0001682735","reported_name":"Peterson Amy C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Immuno-oncology"}}],"security":"American Depositary Shares","published_at":"2018-11-13T15:20:27.000Z","date":"2018-11-08","kind":"sale","acquired":false,"shares":3949,"price":126.0773,"value":497879.2577,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $125.45 to $126.4499, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares, sold at each separate price."}],"balance_after":7873,"source":{"system":"sec-edgar","filing":"0001682735-18-000003","document":"wf-form4_154212240992906.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000168273518000003/wf-form4_154212240992906.xml","form_type":"4"}},{"id":3766194,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":79715,"kind":"person","name":"Peterson Amy C.","position":1,"cik":"0001682735","reported_name":"Peterson Amy C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Immuno-oncology"}}],"security":"American Depositary Shares","published_at":"2018-11-13T15:20:27.000Z","date":"2018-11-08","kind":"sale","acquired":false,"shares":2423,"price":124.4759,"value":301605.1057,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $124.18 to $125.1799, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares, sold at each separate price."}],"balance_after":11822,"source":{"system":"sec-edgar","filing":"0001682735-18-000003","document":"wf-form4_154212240992906.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000168273518000003/wf-form4_154212240992906.xml","form_type":"4"}},{"id":3766193,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":79715,"kind":"person","name":"Peterson Amy C.","position":1,"cik":"0001682735","reported_name":"Peterson Amy C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Immuno-oncology"}}],"security":"American Depositary Shares","published_at":"2018-11-13T15:20:27.000Z","date":"2018-11-08","kind":"sale","acquired":false,"shares":466,"price":122.8565,"value":57251.129,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $122.34 to $123.3399, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares, sold at each separate price."}],"balance_after":14245,"source":{"system":"sec-edgar","filing":"0001682735-18-000003","document":"wf-form4_154212240992906.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000168273518000003/wf-form4_154212240992906.xml","form_type":"4"}},{"id":3766192,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":79715,"kind":"person","name":"Peterson Amy C.","position":1,"cik":"0001682735","reported_name":"Peterson Amy C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Immuno-oncology"}}],"security":"American Depositary Shares","published_at":"2018-11-13T15:20:27.000Z","date":"2018-11-08","kind":"exercise","acquired":true,"shares":14711,"price":29.1,"value":428090.1,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The exercise price is represented in American Depositary Shares."}],"balance_after":14711,"source":{"system":"sec-edgar","filing":"0001682735-18-000003","document":"wf-form4_154212240992906.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000168273518000003/wf-form4_154212240992906.xml","form_type":"4"}},{"id":3834108,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":79715,"kind":"person","name":"Peterson Amy C.","position":1,"cik":"0001682735","reported_name":"Peterson Amy C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Immuno-oncology"}}],"security":"American Depositary Shares","published_at":"2018-08-24T20:25:05.000Z","date":"2018-08-23","kind":"sale","acquired":false,"shares":961,"price":170.4634,"value":163815.3274,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $170.30 to $170.87, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001179110-18-010878","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000117911018010878/edgar.xml","form_type":"4"}},{"id":3834107,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":79715,"kind":"person","name":"Peterson Amy C.","position":1,"cik":"0001682735","reported_name":"Peterson Amy C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Immuno-oncology"}}],"security":"American Depositary Shares","published_at":"2018-08-24T20:25:05.000Z","date":"2018-08-23","kind":"sale","acquired":false,"shares":1400,"price":169.7543,"value":237656.02,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $169.27 to $170.19, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":961,"source":{"system":"sec-edgar","filing":"0001179110-18-010878","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000117911018010878/edgar.xml","form_type":"4"}},{"id":3834106,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":79715,"kind":"person","name":"Peterson Amy C.","position":1,"cik":"0001682735","reported_name":"Peterson Amy C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Immuno-oncology"}}],"security":"American Depositary Shares","published_at":"2018-08-24T20:25:05.000Z","date":"2018-08-23","kind":"sale","acquired":false,"shares":2300,"price":168.9414,"value":388565.22,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $168.25 to $169.24, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":2361,"source":{"system":"sec-edgar","filing":"0001179110-18-010878","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000117911018010878/edgar.xml","form_type":"4"}},{"id":3834105,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":79715,"kind":"person","name":"Peterson Amy C.","position":1,"cik":"0001682735","reported_name":"Peterson Amy C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Immuno-oncology"}}],"security":"American Depositary Shares","published_at":"2018-08-24T20:25:05.000Z","date":"2018-08-23","kind":"sale","acquired":false,"shares":1108,"price":167.536,"value":185629.888,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $167.05 to $167.77, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":4661,"source":{"system":"sec-edgar","filing":"0001179110-18-010878","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000117911018010878/edgar.xml","form_type":"4"}},{"id":3881462,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":79715,"kind":"person","name":"Peterson Amy C.","position":1,"cik":"0001682735","reported_name":"Peterson Amy C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Immuno-oncology"}}],"security":"Share Option (Right to Buy)","published_at":"2018-06-28T23:41:35.000Z","date":"2018-06-26","kind":"grant","acquired":true,"shares":310180,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The number of securities underlying the option and the exercise price therefor are represented in ordinary shares. The exercise price is equal to 1/13 of the closing price of our American Depositary Shares (\"ADSs\") on the date of grant, as each ADS represents 13 ordinary shares."},{"field":"shares","element":"transactionShares","label":"F2","text":"The number of securities underlying the option and the exercise price therefor are represented in ordinary shares. The exercise price is equal to 1/13 of the closing price of our American Depositary Shares (\"ADSs\") on the date of grant, as each ADS represents 13 ordinary shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These securities vest over a four-year period as follows: 25% on June 26, 2019, and the remaining in 36 successive equal monthly installments, subject to continued service. Unvested shares are subject to accelerated vesting upon certain termination events following a change in control."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"The number of securities underlying the option and the exercise price therefor are represented in ordinary shares. The exercise price is equal to 1/13 of the closing price of our American Depositary Shares (\"ADSs\") on the date of grant, as each ADS represents 13 ordinary shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The number of securities underlying the option and the exercise price therefor are represented in ordinary shares. The exercise price is equal to 1/13 of the closing price of our American Depositary Shares (\"ADSs\") on the date of grant, as each ADS represents 13 ordinary shares."}],"balance_after":310180,"derivative":{"exercise_price":12.34,"expiration_date":"2028-06-25","underlying":"Ordinary Shares","underlying_shares":310180},"source":{"system":"sec-edgar","filing":"0001179110-18-009112","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000117911018009112/edgar.xml","form_type":"4"}},{"id":3881461,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":79715,"kind":"person","name":"Peterson Amy C.","position":1,"cik":"0001682735","reported_name":"Peterson Amy C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Immuno-oncology"}}],"security":"Ordinary Shares","published_at":"2018-06-28T23:41:35.000Z","date":"2018-06-26","kind":"grant","acquired":true,"shares":44564,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents securities underlying restricted share units. 1/4th of the securities will vest on each anniversary of June 26, 2018, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control."}],"balance_after":269566,"source":{"system":"sec-edgar","filing":"0001179110-18-009112","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000117911018009112/edgar.xml","form_type":"4"}},{"id":4162348,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":79715,"kind":"person","name":"Peterson Amy C.","position":1,"cik":"0001682735","reported_name":"Peterson Amy C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Immuno-oncology"}}],"security":"American Depositary Shares","published_at":"2017-11-16T01:11:42.000Z","date":"2017-11-13","kind":"sale","acquired":false,"shares":1201,"price":83.3091,"value":100054.2291,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.13 to $84.04, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001179110-17-014170","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000117911017014170/edgar.xml","form_type":"4"}},{"id":4162347,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":79715,"kind":"person","name":"Peterson Amy C.","position":1,"cik":"0001682735","reported_name":"Peterson Amy C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Immuno-oncology"}}],"security":"American Depositary Shares","published_at":"2017-11-16T01:11:42.000Z","date":"2017-11-13","kind":"sale","acquired":false,"shares":2400,"price":82.7887,"value":198692.88,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.12 to $83.11, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":1201,"source":{"system":"sec-edgar","filing":"0001179110-17-014170","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000117911017014170/edgar.xml","form_type":"4"}},{"id":4225646,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":79715,"kind":"person","name":"Peterson Amy C.","position":1,"cik":"0001682735","reported_name":"Peterson Amy C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Immuno-oncology"}}],"security":"Ordinary Shares","published_at":"2017-08-24T20:20:39.000Z","date":"2017-08-22","kind":"tax_withholding","acquired":false,"shares":28185,"price":5.3869,"value":151829.7765,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld to settle tax liability in connection with the vesting of a restricted share award that was previously granted on August 22, 2016. The share withholding was approved by a committee of non-employee directors in accordance with requirements of Rule 16b-3."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Calculated based off the closing price of the Company's American Depositary Shares (\"ADSs\") on the date thereof. Each ADS represents 13 Ordinary Shares."}],"balance_after":271815,"source":{"system":"sec-edgar","filing":"0001179110-17-011812","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000117911017011812/edgar.xml","form_type":"4"}},{"id":4270266,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":79715,"kind":"person","name":"Peterson Amy C.","position":1,"cik":"0001682735","reported_name":"Peterson Amy C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Immuno-oncology"}}],"security":"Share Option (Right to Buy)","published_at":"2017-06-29T23:04:59.000Z","date":"2017-06-27","kind":"grant","acquired":true,"shares":1016178,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The number of securities underlying each option and the exercise price therefore are represented in ordinary shares.  The exercise price is equal to 1/13 of the closing price of our American Depositary Shares (\"ADSs\") on the date of grant, as each ADS represents 13 ordinary shares."},{"field":"shares","element":"transactionShares","label":"F1","text":"The number of securities underlying each option and the exercise price therefore are represented in ordinary shares.  The exercise price is equal to 1/13 of the closing price of our American Depositary Shares (\"ADSs\") on the date of grant, as each ADS represents 13 ordinary shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest over a four-year period as follows: 25% on the first anniversary of the date of grant, with the remaining shares vesting in 36 equal successive monthly installments on the last day of each month thereafter.  Unvested options are subject to accelerated vesting upon certain termination events following a change in control."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"The number of securities underlying each option and the exercise price therefore are represented in ordinary shares.  The exercise price is equal to 1/13 of the closing price of our American Depositary Shares (\"ADSs\") on the date of grant, as each ADS represents 13 ordinary shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The number of securities underlying each option and the exercise price therefore are represented in ordinary shares.  The exercise price is equal to 1/13 of the closing price of our American Depositary Shares (\"ADSs\") on the date of grant, as each ADS represents 13 ordinary shares."}],"balance_after":1016178,"derivative":{"exercise_price":3.49,"expiration_date":"2027-06-26","underlying":"Ordinary shares","underlying_shares":1016178},"source":{"system":"sec-edgar","filing":"0001179110-17-009798","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000117911017009798/edgar.xml","form_type":"4"}}]}